Effects of opsonization and gamma interferon on growth of Brucella melitensis 16M in mouse peritoneal macrophages in vitro

Infection and Immunity

Volumn 68, Issue 1, 2000, Pages 257-263

  Eze, Michael O ^a,c   Yuan, Liang ^a   Crawford, Robert M ^b,d   Paranavitana, Chrysanthi M ^a   Hadfield, Ted L ^b   Bhattacharjee, Apurba K ^a   Warren, Richard L ^a,e   Hoover, David L ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^c UNIVERSITY OF WINNIPEG   (Canada)

^d Hemagen Diagnostics Inc   (United States)

^e Dugway Proving Ground   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; GAMMA INTERFERON; GENTAMICIN; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL CELL; ARTICLE; BACTERIAL GROWTH; BRUCELLA MELITENSIS; BRUCELLOSIS; COLONY FORMING UNIT; CONTROLLED STUDY; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; OPSONIZATION; PERITONEUM MACROPHAGE; PRIORITY JOURNAL;

EID: 0033981499     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.1.257-263.2000     Document Type: Article

References (40)

1. Baldwin, C. L., and A. J. Winter. 1994. Macrophages and Brucella. Immunol. Ser. 60:363-380.
2. Baumler, A. J., and F. Heffron. 1995. Microbial resistance of macrophage effector functions: strategies for evading microbicidal mechanisms and scavenging nutrients within mononuclear phagocytes, p. 115-131. In J. A. Roth, C. A. Bolin, K. A. Brogden, F. C. Minion, and M. J. Wannemuehler (ed.), Virulence mechanisms of bacterial pathogens, 2nd ed. ASM Press, Washington, D.C.
3. Blackwell, J. M., R. A. Ezekowitz, M. B. Roberts, J. Y. Channon, R. B. Sim, and S. Gordon. 1985. Macrophage complement and lectin-like receptors bind Leishmania in the absence of serum. J. Exp. Med. 162:324-331.
4. Bounous, D. I., F. M. Enright, K. A. Gossett, and C. M. Berry. 1993. Phagocytosis, killing, and oxidant production by bovine monocyte-derived macrophages upon exposure to Brucella abortus strain 2308. Vet. Immunol. Immunopathol. 37:243-256.
5. Bundle, D. R., J. W. Cherwonogrodzky, M. Caroff, and M. B. Perry. 1987. The lipopolysaccharides of Brucella abortus and B. melitensis. Ann. Inst. Pasteur Microbiol. 138:92-98.
6. Canning, P. C., B. L. Deyoe, and J. A. Roth. 1988. Opsonin-dependent stimulation of bovine neutrophil oxidative metabolism by Brucella abortus. Am. J. Vet. Res. 49:160-163.
7. Cheers, C., and M. Ho. 1983. Resistance and susceptibility of mice to bacterial infection. IV. Functional specificity in natural resistance to facultative intracellular bacteria. J. Reticuloendothel. Soc. 34:299-309.
8. Drazek, E. S., H. S. Houng, R. M. Crawford, T. L. Hadfield, D. L. Hoover, and R. L. Warren. 1995. Deletion of purE attenuates Brucella melitensis 16M for growth in human monocyte-derived macrophages. Infect. Immun. 63: 3297-3301.
9. Drevets, D. A., B. P. Canono, P. J. Leenen, and P. A. Campbell. 1994. Gentamicin kills intracellular Listeria monocytogenes. Infect. Immun. 62: 2222-2228.
10. Elzer, P. H., R. H. Jacobson, S. M. Jones, K. H. Nielsen, J. T. Douglas, and A. J. Winter. 1994. Antibody-mediated protection against Brucella abortus in BALB/c mice at successive periods after infection: variation between virulent strain 2308 and attenuated vaccine strain 19. Immunology 82:651-658.
11. Elzer, P. H., R. W. Phillips, G. T. Robertson, and R. M. Roop II. 1996. The HtrA stress response protease contributes to resistance of Brucella abortus to killing by murine phagocytes. Infect. Immun. 64:4838-4841.
12. Fortier, A. H., C. A. Nacy, T. Polsinelli, and N. Bhatnagar. 1995. Francisella tularensis, a model pathogen to study the interactin of facultative intracellular bacteria with phagocytic host cells, p. 115-131. In J. A. Roth, C. A. Bolin, K. A. Brogden, F. C. Minion, and M. J. Wannemuehler (ed.), Virulence mechanisms of bacterial pathogens, 2nd ed. ASM Press, Washington, D.C.
13. Fortier, A. H., T. Polsinelli, S. J. Green, and C. A. Nacy. 1992. Activation of macrophages for destruction of Francisella tularensis: identification of cytokines, effector cells, and effector molecules. Infect. Immun. 60:817-825.
14. Gross, A., S. Spiesser, A. Terraza, B. Rouot, E. Caron, and J. Dornand. 1998. Expression and bactericidal activity of nitric oxide synthase in Brucella suis-infected murine macrophages. Infect. Immun. 66:1309-1316.
15. Ischiropoulos, H., L. Zhu, and J. S. Beckman. 1992 Peroxynitrite formation from macrophage-derived nitric oxide. Arch. Biochem. Biophys. 298:446-451.
16. Jiang, X., and C. L. Baldwin. 1993. Effects of cytokines on intracellular growth of Brucella abortus. Infect. Immun. 61:124-134.
17. Jiang, X., B. Leonard, R. Benson, and C. L. Baldwin. 1993. Macrophage control of Brucella abortus: role of reactive oxygen intermediates and nitric oxide. Cell. Immunol. 151:309-319.
18. Jones, S. M., and A. J. Winter. 1992. Survival of virulent and attenuated strains of Brucella abortus in normal and gamma interferon-activated murine peritoneal macrophages. Infect. Immun. 60:3011-3014.
19. Levitz, S. M., and A. Tabuni. 1991. Binding of Cryptococcus neoformans by human cultured macrophages. Requirements for multiple complement receptors and actin. J. Clin. Investig. 87:528-535.
20. Mackaness, G. B. 1964. The immunological basis of acquired cellular resistance. J. Exp. Med. 120:105-120.
21. Mackaness, G. B. 1971. Resistance to intracellular infection. J. Infect. Dis. 123:439-445.
22. Montaraz, J. A., and A. J. Winter. 1986. Comparison of living and nonliving vaccines for Brucella abortus in BALB/c mice. Infect. Immun. 53:245-251.
23. Mortensen, J. E., D. G. Moore, J. E. Clarridge, and E. J. Young. 1986. Antimicrobial susceptibility of clinical isolates of Brucella. Diagn. Microbiol. Infect. Dis. 5:163-169.
24. Musher, D. M., M. Hague-Park, R. E. Baughn, R. J. Wallace, Jr., and B. Cowley. 1983. Opsonizing and bactericidal effects of normal human serum on nontypable Haemophilus influenzae. Infect. Immun. 39:297-304.
25. Newman, S. L., and R. B. Johnston, Jr. 1979. Role of binding through C3b and IgG in polymorphonuclear neutrophil function: studies with trypsin-generated C3b. J. Immunol. 123:1839-1846.
26. Oliveira, S. C., and G. A. Splitter. 1995. CD8+ type 1 CD44hi CD45 RBlo T lymphocytes control intracellular Brucella abortus infection as demonstrated in major histocompatibility complex class I- and class II-deficient mice, Eur. J. Immunol. 25:2551-2557.
27. Payne, N. R., and M. A. Horwitz. 1987. Phagocytosis of Legionella pneumophila is mediated by human monocyte complement receptors. J. Exp. Med. 166:1377-1389.
28. Pizarro-Cerda, J., S. Meresse, R. G. Parton, G. van der Goot, A. Sola-Landa, I. Lopez-Goni, E. Moreno, and J. P. Gorvel. 1998. Brucella abortus transits through the autophagic pathway and replicates in the endoplasmic reticulum of nonprofessional phagocytes. Infect. Immun. 66:5711-5724.
29. Plommet, M., and A. M. Plommet. 1983. Immune serum-mediated effects on brucellosis evolution in mice. Infect. Immun. 41:97-105.
30. Price, R. E., J. W. Templeton, R. D. Smith, and L. G. Adams. 1990. Ability of mononuclear phagocytes from cattle naturally resistant or susceptible to brucellosis to control in vitro intracellular survival of Brucella abortus. Infect. Immun. 58:879-886.
31. Samsom, J. N., J. A. Langermans, P. H. Groeneveld, and R. van Furth. 1996. Acquired resistance against a secondary infection with Listeria monocytogenes in mice is not dependent on reactive nitrogen intermediates. Infect. Immun. 64:1197-1202.
32. Schlesinger, L. S. 1993. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J. Immunol. 150:2920-2930.
33. Schlesinger, L. S., C. G. Bellinger-Kawahara, N. R. Payne, and M. A. Horwitz. 1990. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. J. Immunol. 144:2771-2780.
34. Vazquez-Torres, A., J. Jones-Carson, and E. Balish. 1995. Nitric oxide production does not directly increase macrophage candidacidal activity. Infect. Immun. 63:1142-1144.
35. Winter, A. J., J. R. Duncan, C. G. Santisteban, J. T. Douglas, and L. G. Adams. 1989. Capacity of passively administered antibody to prevent establishment of Brucella abortus infection in mice. Infect. Immun. 57:3438-3444.
36. Wright, S. D., and S. C. Silverstein. 1983. Receptors for C3b and C3bi promote phagocytosis but not the release of toxic oxygen from human phagocytes. J. Exp. Med. 158:2016-2023.
37. Yamamoto, K., and R. B. Johnston, Jr. 1984. Dissociation of phagocytosis from stimulation of the oxidative metabolic burst in macrophages. J. Exp. Med. 159:405-416.
38. Young, E. J., M. Borchert, F. L. Kretzer, and D. M. Musher. 1985. Phagocytosis and killing of Brucella by human polymorphonuclear leukocytes. J. Infect. Dis. 151:682-690.
39. Zhan, Y., and C. Cheers. 1993. Endogenous gamma interferon mediates resistance to Brucella abortus infection. Infect. Immun. 61:4899-4901.
40. Zhan, Y., and C. Cheers. 1995. Endogenous interleukin-12 is involved in resistance to Brucella abortus infection. Infect. Immun. 63:1387-1390.